What is the latest LTTS stock price?
The latest stored price for LTTS is Rs 3,604.60 as of 2026-08-21.
gimli
LTTS stock AI analysis
LTTS Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers
L&T TECHNOLOGY SER. LTD. is a small-cap stock in Information Technology. This Gimli page shows the latest available LTTS price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
Price
₹3,604.60
1W return
+3.68%
1M return
+9.02%
3M return
+0.48%
6M return
+6.12%
1Y return
-15.97%
Market cap
₹38,233.49 cr
PE
28.95
PB
5.89
ROE
+20.98%
ROCE
+19.91%
RSI
57.58
Turnover
₹19.75 cr
Why it can matter in screens
- Momentum: LTTS is above 50DMA, below 200DMA; RSI is 57.58.
- Returns: 1D +0.71%, 1W +3.68%, 1M +9.02%, 3M +0.48%, 1Y -15.97%.
- Trend levels: 52W high ₹3,708.00, 52W low ₹3,030.00, off high -2.79%.
- Liquidity: latest turnover is ₹19.75 cr; volume vs 20D is +0.51%.
- Valuation/profitability: PE 28.95, PB 5.89, ROE +20.98%, ROCE +19.91%.
- Growth: 3Y sales CAGR +7.64%, 3Y profit CAGR +1.81%.
Quick Answers
Is LTTS above its 50DMA and 200DMA?
LTTS is above 50DMA, below 200DMA. The latest 50DMA is 3,408.99 and the latest 200DMA is 3,708.36.
What are LTTS PE, ROE and ROCE?
LTTS has PE 28.95, ROE +20.98%, and ROCE +19.91% in Gimli's latest available snapshot.
How has LTTS performed recently?
LTTS has returned +9.02% over 1 month, +0.48% over 3 months, and -15.97% over 12 months in the latest stored data.
Is this stock page investment advice?
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
Financials and Ownership
Quarterly income statement
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-06-30 | 2,940.10 cr | 577.40 cr | 356.60 cr | 33.62 |
| 2026-03-31 | 2,857.90 cr | 539.70 cr | 332.10 cr | 31.34 |
| 2025-12-31 | 2,923.50 cr | 511.70 cr | 302.60 cr | 28.56 |
| 2025-09-30 | 3,045.00 cr | 556.40 cr | 329.20 cr | 30.97 |
| 2025-06-30 | 2,866.00 cr | 530.10 cr | 315.70 cr | 29.81 |
| 2025-03-31 | 2,637.80 cr | 481.80 cr | 311.10 cr | 29.38 |
| 2024-12-31 | 2,653.00 cr | 528.20 cr | 322.40 cr | 30.47 |
| 2024-09-30 | 2,572.90 cr | 531.00 cr | 319.60 cr | 30.20 |
Annual income statement
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 10,995.90 cr | 2,086.10 cr | 1,279.20 cr | 120.71 |
| 2025-03-31 | 9,642.20 cr | 2,001.20 cr | 1,266.70 cr | 119.70 |
| 2024-03-31 | 9,647.30 cr | 2,126.30 cr | 1,303.70 cr | 123.34 |
| 2023-03-31 | 8,815.50 cr | 1,964.20 cr | 1,212.10 cr | 114.82 |
| 2022-03-31 | 6,569.70 cr | 1,567.30 cr | 957.00 cr | 90.92 |
Balance sheet
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 10,488.90 cr | 1,649.70 cr | 578.50 cr | 6,492.20 cr |
| 2025-03-31 | 9,643.50 cr | 1,383.10 cr | 577.60 cr | 6,097.50 cr |
| 2024-03-31 | 8,488.50 cr | 1,122.10 cr | 658.80 cr | 5,347.80 cr |
| 2023-03-31 | 8,197.60 cr | 534.60 cr | 454.20 cr | 4,452.90 cr |
| 2022-03-31 | 6,091.00 cr | 234.70 cr | 477.10 cr | 4,176.20 cr |
Cash flow
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | 1,455.10 cr | 1,270.00 cr | n/a |
| 2025-03-31 | 1,481.10 cr | 1,369.50 cr | n/a |
| 2024-03-31 | 1,492.80 cr | 1,240.00 cr | n/a |
| 2023-03-31 | 1,313.00 cr | 1,131.50 cr | n/a |
| 2022-03-31 | 1,006.20 cr | 843.80 cr | n/a |
Shareholding Trend
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-06-30 | +73.52% | +4.12% | +14.05% | +3.69% | +8.30% | +0.00% |
| 2026-03-31 | +73.57% | +3.86% | +14.64% | +4.32% | +7.93% | +0.00% |
| 2025-12-31 | +73.58% | +4.23% | +14.57% | +4.28% | +7.62% | +0.00% |
| 2025-09-30 | +73.58% | +4.67% | +14.13% | +4.14% | +7.61% | +0.00% |
| 2025-06-30 | +73.59% | +4.84% | +13.88% | +4.09% | +7.69% | +0.00% |
| 2025-03-31 | +73.66% | +5.18% | +13.68% | +4.06% | +7.48% | +0.00% |
| 2024-12-31 | +73.66% | +4.19% | +14.30% | +4.64% | +7.86% | +0.00% |
| 2024-09-30 | +73.69% | +4.35% | +13.96% | +4.32% | +8.01% | +0.00% |
| 2024-06-30 | +73.69% | +4.46% | +13.31% | +3.61% | +8.54% | +0.00% |
| 2024-03-31 | +73.74% | +5.51% | +12.33% | +2.85% | +8.41% | +0.00% |
| 2023-12-31 | +73.75% | +5.63% | +11.57% | +2.73% | +9.05% | +0.00% |
| 2023-09-30 | +73.77% | +5.90% | +11.01% | +2.31% | +9.32% | +0.00% |
| 2023-06-30 | +73.80% | +5.31% | +10.61% | +2.16% | +10.28% | +0.00% |
| 2023-03-31 | +73.85% | +6.69% | +8.64% | +1.64% | +10.83% | +0.00% |
| 2022-12-31 | +73.85% | +7.22% | +7.92% | +2.06% | +11.01% | +0.00% |
| 2022-09-30 | +73.87% | +6.04% | +8.23% | +2.60% | +11.87% | +0.00% |
| 2022-06-30 | +73.88% | +0.00% | +10.42% | n/a | n/a | +0.00% |
| 2022-03-31 | +73.90% | +0.00% | +12.34% | n/a | n/a | +0.00% |
| 2021-12-31 | +73.93% | +0.00% | +14.65% | n/a | n/a | +0.00% |
| 2021-09-30 | +74.15% | +0.00% | +15.64% | n/a | n/a | +0.00% |
Industry Peers
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| TCS | TATA CONSULTANCY SERV LT | 832,883.74 cr | 16.706123 | +48.82% | -25.80% |
| INFY | INFOSYS LIMITED | 453,669.59 cr | 18.051543 | +23.83% | -25.09% |
| HCLTECH | HCL TECHNOLOGIES LTD | 352,411.23 cr | 22.241163 | +21.87% | -12.79% |
| WIPRO | WIPRO LTD | 189,560.27 cr | 14.339986 | +15.39% | -27.66% |
| TECHM | TECH MAHINDRA LIMITED | 140,297.81 cr | 27.279902 | +17.77% | +4.12% |
| LTM | LTM LIMITED | 133,045.86 cr | 25.535653 | +22.26% | -14.27% |
| OFSS | ORACLE FIN SERV SOFT LTD. | 102,071.96 cr | 29.907691 | +42.16% | +34.77% |
| PERSISTENT | PERSISTENT SYSTEMS LTD | 88,543.92 cr | 46.039413 | +27.17% | +5.98% |
Try these prompts
- Analyze L&T TECHNOLOGY SER.. with valuation, momentum and industry peers
- Compare LTTS with other Information Technology stocks
- Show small-cap stocks in Information Technology above 50DMA with positive 1M return
- Find Information Technology stocks with improving momentum and reasonable valuation
Related screen ideas
- View Information Technology stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare LTTS with other Information Technology stocks
Data snapshot: 2026-08-21. Not investment advice.